Revolade Trademark Details

Revolade was registered on Tuesday, November 7, 2006 and is currently owned by Glaxosmithkline LLC under the registration number 3167840 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 10 years ago on Friday, June 14, 2013, according to the United State Patent & Trademark Office
Word Mark Revolade
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Glaxosmithkline LLC of Wilmington, DE

View all trademarks for Glaxosmithkline LLC
Other Trademarks for Glaxosmithkline LLC

Previous Owners

Smithkline Beecham Corporation of Philadelphia, PA

View all trademarks for Smithkline Beecham Corporation
Other Trademarks for Smithkline Beecham Corporation

Glaxo Group Limited

View all trademarks for Glaxo Group Limited
Serial Number 78667507
Registration Number 3167840
Status Date Friday, June 14, 2013
Filing Date Friday, June 14, 2013
Registration Date Tuesday, November 7, 2006
Attorney Diane Fry Maginnis
Domestic Representative Diane Fry Maginnis

Correspondent

Diane Fry Maginnis
GlaxoSmithKline
LGTM, C.3157.3D
Five Moore Drive
Research Triangle Park NC 27709

Case File Statements

Goods & Services Pharmaceutical preparations and substances for the treatment of infectious diseases, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders and for the treatment of damaged skin and tissue; and for vaccines

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, June 14, 2013
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.